Cargando…

Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine

Individuals with diabetes mellitus present a skeletal muscle myopathy characterized by atrophy. However, the mechanism underlying this muscular alteration remains elusive, which makes it difficult to design a rational treatment that could avoid the negative consequences in muscles due to diabetes. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Cea, Luis A., Vásquez, Walter, Hernández-Salinas, Romina, Vielma, Alejandra Z., Castillo-Ruiz, Mario, Velarde, Victoria, Salgado, Magdiel, Sáez, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136059/
https://www.ncbi.nlm.nih.gov/pubmed/37189454
http://dx.doi.org/10.3390/biom13040708
_version_ 1785032125080141824
author Cea, Luis A.
Vásquez, Walter
Hernández-Salinas, Romina
Vielma, Alejandra Z.
Castillo-Ruiz, Mario
Velarde, Victoria
Salgado, Magdiel
Sáez, Juan C.
author_facet Cea, Luis A.
Vásquez, Walter
Hernández-Salinas, Romina
Vielma, Alejandra Z.
Castillo-Ruiz, Mario
Velarde, Victoria
Salgado, Magdiel
Sáez, Juan C.
author_sort Cea, Luis A.
collection PubMed
description Individuals with diabetes mellitus present a skeletal muscle myopathy characterized by atrophy. However, the mechanism underlying this muscular alteration remains elusive, which makes it difficult to design a rational treatment that could avoid the negative consequences in muscles due to diabetes. In the present work, the atrophy of skeletal myofibers from streptozotocin-induced diabetic rats was prevented with boldine, suggesting that non-selective channels inhibited by this alkaloid are involved in this process, as has previously shown for other muscular pathologies. Accordingly, we found a relevant increase in sarcolemma permeability of skeletal myofibers of diabetic animals in vivo and in vitro due to de novo expression of functional connexin hemichannels (Cx HCs) containing connexins (Cxs) 39, 43, and 45. These cells also expressed P2X(7) receptors, and their inhibition in vitro drastically reduced sarcolemma permeability, suggesting their participation in the activation of Cx HCs. Notably, sarcolemma permeability of skeletal myofibers was prevented by boldine treatment that blocks Cx43 and Cx45 HCs, and now we demonstrated that it also blocks P2X(7) receptors. In addition, the skeletal muscle alterations described above were not observed in diabetic mice with myofibers deficient in Cx43/Cx45 expression. Moreover, murine myofibers cultured for 24 h in high glucose presented a drastic increase in sarcolemma permeability and levels of NLRP3, a molecular member of the inflammasome, a response that was also prevented by boldine, suggesting that, in addition to the systemic inflammatory response found in diabetes, high glucose can promote the expression of functional Cx HCs and activation of the inflammasome in skeletal myofibers. Therefore, Cx43 and Cx45 HCs play a critical role in myofiber degeneration, and boldine could be considered a potential therapeutic agent to treat muscular complications due to diabetes.
format Online
Article
Text
id pubmed-10136059
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101360592023-04-28 Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine Cea, Luis A. Vásquez, Walter Hernández-Salinas, Romina Vielma, Alejandra Z. Castillo-Ruiz, Mario Velarde, Victoria Salgado, Magdiel Sáez, Juan C. Biomolecules Article Individuals with diabetes mellitus present a skeletal muscle myopathy characterized by atrophy. However, the mechanism underlying this muscular alteration remains elusive, which makes it difficult to design a rational treatment that could avoid the negative consequences in muscles due to diabetes. In the present work, the atrophy of skeletal myofibers from streptozotocin-induced diabetic rats was prevented with boldine, suggesting that non-selective channels inhibited by this alkaloid are involved in this process, as has previously shown for other muscular pathologies. Accordingly, we found a relevant increase in sarcolemma permeability of skeletal myofibers of diabetic animals in vivo and in vitro due to de novo expression of functional connexin hemichannels (Cx HCs) containing connexins (Cxs) 39, 43, and 45. These cells also expressed P2X(7) receptors, and their inhibition in vitro drastically reduced sarcolemma permeability, suggesting their participation in the activation of Cx HCs. Notably, sarcolemma permeability of skeletal myofibers was prevented by boldine treatment that blocks Cx43 and Cx45 HCs, and now we demonstrated that it also blocks P2X(7) receptors. In addition, the skeletal muscle alterations described above were not observed in diabetic mice with myofibers deficient in Cx43/Cx45 expression. Moreover, murine myofibers cultured for 24 h in high glucose presented a drastic increase in sarcolemma permeability and levels of NLRP3, a molecular member of the inflammasome, a response that was also prevented by boldine, suggesting that, in addition to the systemic inflammatory response found in diabetes, high glucose can promote the expression of functional Cx HCs and activation of the inflammasome in skeletal myofibers. Therefore, Cx43 and Cx45 HCs play a critical role in myofiber degeneration, and boldine could be considered a potential therapeutic agent to treat muscular complications due to diabetes. MDPI 2023-04-21 /pmc/articles/PMC10136059/ /pubmed/37189454 http://dx.doi.org/10.3390/biom13040708 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cea, Luis A.
Vásquez, Walter
Hernández-Salinas, Romina
Vielma, Alejandra Z.
Castillo-Ruiz, Mario
Velarde, Victoria
Salgado, Magdiel
Sáez, Juan C.
Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title_full Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title_fullStr Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title_full_unstemmed Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title_short Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine
title_sort skeletal muscle atrophy induced by diabetes is mediated by non-selective channels and prevented by boldine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136059/
https://www.ncbi.nlm.nih.gov/pubmed/37189454
http://dx.doi.org/10.3390/biom13040708
work_keys_str_mv AT cealuisa skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT vasquezwalter skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT hernandezsalinasromina skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT vielmaalejandraz skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT castilloruizmario skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT velardevictoria skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT salgadomagdiel skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine
AT saezjuanc skeletalmuscleatrophyinducedbydiabetesismediatedbynonselectivechannelsandpreventedbyboldine